U
CDMO

UBS’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

UBS’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$78K Sell
8,157
-8,170
-50% -$91.5K ﹤0.01% 6286
2014
Q2 		$215K Buy
16,327
+1,851
+13% +$23.3K ﹤0.01% 5072
2014
Q1 		$192K Buy
14,476
+7,966
+122% +$105K ﹤0.01% 5232
2013
Q4 		$63K Buy
6,510
+5,981
+1,131% +$56.3K ﹤0.01% 6665
2013
Q3 		$5K Sell
529
-3,571
-87% -$35.5K ﹤0.01% 9437
2013
Q2 		$37K Buy
+4,100
New +$43K ﹤0.01% 7136

Other funds holding CDMO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

UBS's CDMO Position: Q3 2014 in Review

UBS reduced its Avid Bioservices, Inc. Common Stock (CDMO) stake by 50% in Q3 2014, selling an estimated $91.5K and leaving 8,157 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #6286.

UBS first reported a position in CDMO in Q2 2013 and has held it in 6 quarters since. The position peaked at $215K in Q2 2014. 79 funds tracked by Wall St. Rank hold CDMO as of Q3 2014.

  • UBS held 8,157 shares of Avid Bioservices, Inc. Common Stock worth $78K as of Q3 2014.
  • UBS sold 8,170 Avid Bioservices, Inc. Common Stock shares in Q3 2014, an estimated $91.5K.
  • Avid Bioservices, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6286 holding.
  • UBS first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • UBS's Avid Bioservices, Inc. Common Stock position peaked at $215K in Q2 2014.
  • 79 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.